No significant differences in clinical characteristics (age, sex, IgG levels) or CLL genetic features (IGHV and TP53 mutational status, del17p) were observed between patients who developed and did not develop reinfection. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.